These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9354506)

  • 1. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation.
    Whyte RI; Rossi SJ; Mulligan MS; Florn R; Baker L; Gupta S; Martinez FJ; Lynch JP
    Ann Thorac Surg; 1997 Oct; 64(4):945-8. PubMed ID: 9354506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
    Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
    Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage therapy with mycophenolate mofetil for lung transplant bronchiolitis obliterans: importance of dosage.
    Speich R; Boehler A; Thurnheer R; Weder W
    Transplantation; 1997 Aug; 64(3):533-5. PubMed ID: 9275125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation.
    Groetzner J; Wittwer T; Kaczmarek I; Ueberfuhr P; Strauch J; Nagib R; Meiser B; Franke U; Reichart B; Wahlers T
    Transplantation; 2006 Feb; 81(3):355-60. PubMed ID: 16477220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment.
    Verleden GM
    Monaldi Arch Chest Dis; 2000 Apr; 55(2):140-5. PubMed ID: 10949876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
    Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
    Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation.
    Miyazaki T; Tagawa T; Yamasaki N; Tsuchiya T; Matsumoto K; Nagayasu T
    Transplant Proc; 2013; 45(1):356-9. PubMed ID: 23375323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression.
    Glanville AR; Baldwin JC; Burke CM; Theodore J; Robin ED
    Ann Intern Med; 1987 Sep; 107(3):300-4. PubMed ID: 3113308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
    Kwakkel-van Erp JM; Otten HG; Paantjens AW; van Kessel DA; van Ginkel WG; van den Bosch JM; van de Graaf EA
    J Heart Lung Transplant; 2008 Oct; 27(10):1172-5. PubMed ID: 18926413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early results of single lung transplantation in patients with end-stage pulmonary fibrosis.
    McGregor CG; Dark JH; Hilton CJ; Freeman R; Conacher ID; Corris PA
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):350-4. PubMed ID: 2671509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome.
    Sithamparanathan S; Thirugnanasothy L; Morley KE; Fisher AJ; Lordan JL; Meachery G; Parry G; Corris PA
    Transplant Proc; 2016 Dec; 48(10):3387-3392. PubMed ID: 27931586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy.
    Kramer MR; Stoehr C; Whang JL; Berry GJ; Sibley R; Marshall SE; Patterson GM; Starnes VA; Theodore J
    J Heart Lung Transplant; 1993; 12(4):675-81. PubMed ID: 8369329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of obliterative bronchiolitis after heart-lung transplantation in children.
    Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M
    J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
    Speich R; Schneider S; Hofer M; Irani S; Vogt P; Weder W; Boehler A
    Pulm Pharmacol Ther; 2010 Oct; 23(5):445-9. PubMed ID: 20394831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.